Q1: 2026-05-05 Earnings Summary EPS of -$0.40 misses by $0.09  |  Revenue of $10.79M (0.81% Y/Y) misses by $1.92M Ocular Therapeutix, Inc. ( OCUL ) Bank of America Global Healthcare Conference 2026 May 12, 2026 6:40 PM EDT Company Participants Pravin Dugel - Executive Chairman, President & CEO Conference Call Participants Tazeen Ahmad - BofA Securities, Research Division Tara Bancroft - TD Cowen, Research Division Presentation Tazeen Ahmad BofA Securities, Research Division Ocular Therapeutics. Presenting for Ocular today and sitting up on stage with me is Dr. Pravin Dugel, who is, of course, CEO of the company. Dr. Dugel, I call you Pravin. Thank you for making the trip out here. Pravin Dugel Executive Chairman, President & CEO Tazeen, thank you. Thanks for having us here. It's always a wonderful meeting and really appreciate the opportunity to speak with you and to be in this meeting. Thank you. Tazeen Ahmad BofA Securities, Research Division I should actually refer to you as Dr.…